{"chain_id": "chain_000000", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25891233, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with likelihood of abstinence when treated with nicotine in people with Tobacco Use Disorder as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs1051730 and nicotine in Other:Tobacco Use Disorder (PMID 25891233), what OR was reported?", "answer": "0.89", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000001", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22328925, is the following pharmacogenomic claim supported or contradicted: Genotype CC is associated with increased response to peginterferon alfa-2b and ribavirin in people with Hepatitis C and HIV Infections as compared to genotypes AA + AC. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs4803217 and peginterferon alfa-2b, ribavirin in Disease:Hepatitis C virus infection, Disease:HIV infectious disease (PMID 22328925), what p-value was reported for this association?", "answer": "= 0.000013", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000002", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24447405, is the following pharmacogenomic claim supported or contradicted: Allele G is not associated with likelihood of cessation of nicotine in men with Tobacco Use Disorder as compared to allele A. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls were included in the study of rs2036657 and nicotine in Other:Tobacco Use Disorder (PMID 24447405)?", "answer": 146, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000003", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 30914949, is the following pharmacogenomic claim supported or contradicted: Genotype CT is associated with increased risk of Alopecia due to bleomycin, cisplatin and etoposide in men with Testicular Neoplasms as compared to genotype TT. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs2740574 and bleomycin, cisplatin, etoposide in Disease:Testicular Neoplasms (PMID 30914949), what p-value was reported for this association?", "answer": "= 0.058", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000004", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26699619, is the following pharmacogenomic claim supported or contradicted: Genotype TT is associated with increased rapid virological response (rvr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to genotypes GG + GT. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs8099917 and peginterferon alfa-2a, peginterferon alfa-2b, ribavirin in Disease:Chronic hepatitis C virus infection (PMID 26699619)?", "answer": 687, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000005", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 32153387, is the following pharmacogenomic claim supported or contradicted: Allele C is not associated with risk of transplant rejection when treated with tacrolimus in people with Kidney Transplantation as compared to allele T. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs10499563 and tacrolimus in Other:Kidney Transplantation (PMID 32153387), what confidence interval was reported?", "answer": "0.9\u20136.9", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000006", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 37098852, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with clearance of tenofovir in people with HIV Infections as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs1800629 and tenofovir in Other:HIV infectious disease (PMID 37098852), what p-value was reported for this association?", "answer": "= 0.2", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000007", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 32342502, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with increased likelihood of venous thromboembolism when treated with hormonal contraceptives for systemic use. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls were included in the study of rs6025 and hormonal contraceptives for systemic use in Toxicity (PMID 32342502)?", "answer": 487, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000008", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 18574025, is the following pharmacogenomic claim supported or contradicted: CYP2C9 *2 is associated with decreased dose of warfarin. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of CYP2C9*2 and warfarin in Dosage (PMID 18574025)?", "answer": 1321, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000009", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 21743379, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with exposure to lopinavir or ritonavir in children with HIV Infections as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs1045642 and lopinavir, ritonavir in Other:HIV infectious disease (PMID 21743379)?", "answer": 50, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000010", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 40442974, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 40442974, rs11664064 is associated with Dosage, Toxicity outcomes for azathioprine, mercaptopurine. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 40442974 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000011", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25350695, is the following pharmacogenomic claim supported or contradicted: Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele A. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs10455872 and HMG-CoA reductase inhibitors in Efficacy (PMID 25350695)?", "answer": 18075, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000012", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 19901119, is the following pharmacogenomic claim supported or contradicted: Allele G is associated with increased risk of GI toxicity when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele A. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs4149081 and methotrexate in Disease:Acute lymphoblastic leukemia (PMID 19901119)?", "answer": 434, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000013", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23144877, is the following pharmacogenomic claim supported, contradicted, or not reported: Allele A is not associated with likelihood of Vomiting due to heroin in women with Pain, Postoperative as compared to allele G. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 23144877 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000014", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26715213, is the following pharmacogenomic claim supported or contradicted: Genotypes CC + CT are associated with decreased risk of Central Nervous System Diseases when treated with efavirenz in people with HIV Infections as compared to genotype TT. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs28399499 and efavirenz in Disease:HIV infectious disease (PMID 26715213), what OR was reported?", "answer": "0.3", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000015", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24433488, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 24433488, rs121918592 is associated with Dosage, Efficacy outcomes for desflurane, enflurane, halothane, isoflurane, sevoflurane, succinylcholine. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 24433488 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000016", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26892777, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 26892777, SLCO1B1 low activity is associated with Metabolism/PK outcomes for atazanavir. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 26892777 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000017", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23651024, is the following pharmacogenomic claim supported or contradicted: Genotypes CC + CT are associated with increased dose of methadone in people with Heroin Dependence as compared to genotype TT. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs2289658 and methadone in Disease:Heroin Dependence (PMID 23651024), what OR was reported?", "answer": "1.592", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000018", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24123600, is the following pharmacogenomic claim supported or contradicted: Allele C is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs2725252 and imatinib in Disease:Chronic myelogenous leukemia, BCR-ABL1 positive (PMID 24123600), what p-value was reported for this association?", "answer": "= 0.185", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000019", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 7862671, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 7862671, TPMT*1, TPMT*2, TPMT*3A, TPMT*3C, TPMT*9, TPMT*21, TPMT*33, TPMT*34 is associated with Toxicity outcomes for mercaptopurine. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 7862671 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000020", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29705271, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 29705271, rs776817009 is associated with Other outcomes for o-desmethyltramadol. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 29705271 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000021", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 32606912, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with dose of sufentanil in people with Pain, Postoperative as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs842647 and sufentanil in Other:Pain, Postoperative (PMID 32606912), what p-value was reported for this association?", "answer": "= 0.456", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000022", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 32451486, is the following pharmacogenomic claim supported or contradicted: Allele A is associated with decreased risk of Alcoholism due to ethanol as compared to allele G. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls were included in the study of rs2673136 and ethanol in Toxicity (PMID 32451486)?", "answer": 256395, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000023", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 35150001, is the following pharmacogenomic claim supported or contradicted: Genotype TT is not associated with increased likelihood of Peripheral Nervous System Diseases when treated with vincristine in people with Medulloblastoma, Glioma or Brain Neoplasms as compared to genotypes CC + CT. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs924607 and vincristine in Other:Medulloblastoma, Other:Glioma, Other:Brain Neoplasms (PMID 35150001), what confidence interval was reported?", "answer": "0.359\u201311.989", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000024", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25744370, is the following pharmacogenomic claim supported or contradicted: Allele C is not associated with risk of Heroin Dependence due to heroin as compared to allele T. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs647303 and heroin in Toxicity (PMID 25744370), what p-value was reported for this association?", "answer": "= 0.85", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000025", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29743634, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with response to methotrexate in people with Arthritis, Rheumatoid as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs2847153 and methotrexate in Disease:Rheumatoid arthritis (PMID 29743634)?", "answer": 915, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000026", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29415147, is the following pharmacogenomic claim supported or contradicted: Allele C is not associated with risk of Alcoholism due to ethanol as compared to allele A. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs867858 and ethanol in Toxicity (PMID 29415147)?", "answer": 534, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000027", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24967362, is the following pharmacogenomic claim supported or contradicted: Genotypes AG + GG is associated with increased response to methotrexate in people with Arthritis, Rheumatoid as compared to genotype AA. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls were included in the study of rs1801133 and methotrexate in Other:Rheumatoid arthritis (PMID 24967362)?", "answer": 128, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000028", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 21790903, is the following pharmacogenomic claim supported or contradicted: Genotypes GT + TT is associated with increased risk of Cocaine-Related Disorders when exposed to cocaine as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls were included in the study of rs6454674 and cocaine in Other (PMID 21790903)?", "answer": 492, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000029", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23278282, is the following pharmacogenomic claim supported or contradicted: Genotypes CT + TT are associated with increased metabolism of tacrolimus in people with Kidney Transplantation as compared to genotype CC. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs776746 and tacrolimus in Disease:Kidney Transplantation (PMID 23278282), what p-value was reported for this association?", "answer": "< 0.024", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000030", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26745506, is the following pharmacogenomic claim supported or contradicted: Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs9923231 and warfarin in Dosage (PMID 26745506), what p-value was reported for this association?", "answer": "< 0.0001", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000031", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26042510, is the following pharmacogenomic claim supported or contradicted: Genotype AA is associated with increased dose of ethanol as compared to genotype AG. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls were included in the study of rs10485057 and ethanol in Dosage (PMID 26042510)?", "answer": 133, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000032", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 21288825, is the following pharmacogenomic claim supported or contradicted: Genotypes AA + AG is not associated with increased discontinuation of atazanavir and ritonavir in people with HIV Infections as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs1045642 and atazanavir, ritonavir in Disease:HIV infectious disease (PMID 21288825), what p-value was reported for this association?", "answer": "> 0.05", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000033", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26042510, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 26042510, rs1799971 is associated with PD outcomes for nicotine. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 26042510 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000034", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29053440, is the following pharmacogenomic claim supported or contradicted: HLA-B *18:01 is associated with increased likelihood of Epidermal Necrolysis, Toxic and Stevens-Johnson Syndrome when treated with carbamazepine. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of HLA-B*18:01 and carbamazepine in Toxicity (PMID 29053440), what OR was reported?", "answer": "8.0", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000035", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26169577, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with increased likelihood of Cough when treated with Ace Inhibitors, Plain as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls were included in the study of rs7661530 and Ace Inhibitors, Plain in Other (PMID 26169577)?", "answer": 5485, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000036", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 40413606, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 40413606, rs28929495 is associated with Dosage, Efficacy, Toxicity, Metabolism/PK outcomes for afatinib. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 40413606 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000037", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28838926, is the following pharmacogenomic claim supported or contradicted: Allele A is associated with decreased metabolism of clopidogrel, enalapril and sacubitril in HEK cells as compared to allele G. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "functional_assay", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs201065375 and clopidogrel, enalapril, sacubitril in Metabolism/PK (PMID 28838926), what p-value was reported for this association?", "answer": "< 0.001", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000038", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24123600, is the following pharmacogenomic claim supported or contradicted: Allele C is associated with increased response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs2725252 and imatinib in Disease:Chronic myelogenous leukemia, BCR-ABL1 positive (PMID 24123600), what p-value was reported for this association?", "answer": "= 0.025", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000039", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22951632, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with increased response to efavirenz or non-nucleoside reverse transcriptase inhibitors in women with HIV Infections as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs3745274 and efavirenz, non-nucleoside reverse transcriptase inhibitors in Disease:HIV infectious disease (PMID 22951632), what OR was reported?", "answer": "3.61", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000040", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 32004414, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 32004414, CYP2C9*9 is associated with Other outcomes for . Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 32004414 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000041", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23799528, is the following pharmacogenomic claim supported or contradicted: Allele C is not associated with risk of Weight gain when exposed to risperidone in children with Autism Spectrum Disorder as compared to allele T. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs806377 and risperidone in Disease:Autism Spectrum Disorder (PMID 23799528), what p-value was reported for this association?", "answer": "= 0.17", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000042", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28403410, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 28403410, rs112563513 is associated with Metabolism/PK outcomes for caffeine. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 28403410 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000043", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 20679962, is the following pharmacogenomic claim supported or contradicted: Allele C is not associated with increased risk of side effects when treated with mycophenolate mofetil in people with Kidney Transplantation as compared to allele T. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs4974081 and mycophenolate mofetil in Disease:Kidney Transplantation (PMID 20679962)?", "answer": 456, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000044", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 27182616, is the following pharmacogenomic claim supported or contradicted: CYP2C9 *2 is associated with decreased dose of warfarin in children as compared to CYP2C9 *1/*1. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of CYP2C9*1, CYP2C9*2 and warfarin in Dosage (PMID 27182616), what p-value was reported for this association?", "answer": "= 0.193", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000045", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28814798, is the following pharmacogenomic claim supported or contradicted: Genotype CC is associated with decreased risk of Myelosuppression when treated with Platinum compounds and radiotherapy in people with Nasopharyngeal Neoplasms as compared to genotypes AA + AC. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs1059698 and Platinum compounds, radiotherapy in Disease:Nasopharyngeal Neoplasms (PMID 28814798), what OR was reported?", "answer": "0.395", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000046", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22450926, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 22450926, rs11702425 is associated with Metabolism/PK outcomes for methotrexate. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 22450926 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000047", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28049362, is the following pharmacogenomic claim supported or contradicted: Allele T is not associated with Blood Coagulation Disorders when treated with warfarin as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs699664 and warfarin in Efficacy, Toxicity (PMID 28049362), what p-value was reported for this association?", "answer": "= 0.5110", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000048", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25744370, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with risk of Heroin Dependence due to heroin as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs10485060 and heroin in Toxicity (PMID 25744370), what p-value was reported for this association?", "answer": "= 0.23", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000049", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29027195, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 29027195, rs3828743 is associated with Dosage, Other outcomes for abiraterone, prednisolone. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 29027195 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000050", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 19016697, is the following pharmacogenomic claim supported or contradicted: Allele C is not associated with response to methotrexate in people with Psoriasis as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs2372536 and methotrexate in Disease:Psoriasis (PMID 19016697)?", "answer": 330, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000051", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23963147, is the following pharmacogenomic claim supported or contradicted: UGT1A1 *28 is not associated with response to irinotecan, oxaliplatin and s 1 (combination) in people with Colorectal Neoplasms. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of UGT1A1*28 and irinotecan, oxaliplatin, tegafur / gimeracil / oteracil in Disease:Colorectal Neoplasms (PMID 23963147)?", "answer": 42, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000052", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22824134, is the following pharmacogenomic claim supported or contradicted: Genotype AA is associated with decreased risk of Drug Hypersensitivity when treated with sulfamethoxazole in people with HIV Infections as compared to genotypes AC + CC. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs761142 and sulfamethoxazole in Disease:HIV infectious disease (PMID 22824134), what OR was reported?", "answer": "2.2", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000053", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 34476898, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 34476898, CYP2A6 low activity is associated with Metabolism/PK outcomes for nicotine. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 34476898 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000054", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24192532, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 24192532, rs2942857 is associated with Metabolism/PK outcomes for nicotine. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 24192532 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000055", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28376280, is the following pharmacogenomic claim supported or contradicted: Allele del is associated with increased response to ethanol in healthy individuals as compared to allele GGGGGCCCTGCATGCGTCCTGGGGTAGTACACGCTCCAGT. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs28363170 and ethanol in Other (PMID 28376280), what p-value was reported for this association?", "answer": "= 0.007", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000056", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29791014, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with increased concentrations of lamotrigine in people with Epilepsy as compared to allele G. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs2231142 and lamotrigine in Disease:Epilepsy (PMID 29791014), what p-value was reported for this association?", "answer": "< 0.006", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000057", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 18424454, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 18424454, rs3789243 is associated with Dosage, Efficacy, Toxicity outcomes for methadone. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 18424454 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000058", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 39468242, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 39468242, rs4148325 is associated with Toxicity, Metabolism/PK outcomes for . Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 39468242 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000059", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29923122, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 29923122, rs116855232 is associated with Toxicity outcomes for mercaptopurine. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 29923122 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000060", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29871907, is the following pharmacogenomic claim supported or contradicted: Allele G is associated with increased risk of Hypertension due to bevacizumab in people with Colorectal Neoplasms as compared to allele A. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs6929249 and bevacizumab in Disease:Colorectal Neoplasms (PMID 29871907), what confidence interval was reported?", "answer": "5.8\u2013247.0", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000061", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 38004528, is the following pharmacogenomic claim supported or contradicted: Genotypes CT + TT is associated with increased severity of hand-foot syndrome or Drug Toxicity when treated with capecitabine in people with Colorectal Neoplasms as compared to genotype CC. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs71647871 and capecitabine in Other:Colorectal Neoplasms (PMID 38004528)?", "answer": 161, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000062", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23776391, is the following pharmacogenomic claim supported or contradicted: CYP2D6 *10/*10 is associated with decreased event-free survival when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1 + *1/*10. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of CYP2D6*1, CYP2D6*10 and antineoplastic agents, tamoxifen in Disease:Breast Neoplasms (PMID 23776391)?", "answer": 16, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000063", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26914831, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with increased severity of Thrombocytopenia when treated with sunitinib in people with Carcinoma, Renal Cell as compared to allele G. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs2231142 and sunitinib in Disease:Renal Cell Carcinoma (PMID 26914831), what confidence interval was reported?", "answer": "1.172\u20132.939", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000064", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 20590587, is the following pharmacogenomic claim supported or contradicted: CYP2D6 poor metabolizer is associated with decreased concentrations of noroxymorphone in healthy individuals as compared to CYP2D6 ultrarapid metabolizer. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of CYP2D6 poor metabolizer genotype and noroxymorphone in Metabolism/PK (PMID 20590587), what p-value was reported for this association?", "answer": "= 2.8E-5", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000065", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26426352, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 26426352, rs200346442 is associated with Metabolism/PK outcomes for clopidogrel. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 26426352 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000066", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 21882181, is the following pharmacogenomic claim supported or contradicted: Genotype CC is associated with decreased overall survival when treated with sunitinib in people with Carcinoma, Renal Cell. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs2305948 and sunitinib in Disease:Renal Cell Carcinoma (PMID 21882181)?", "answer": 63, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000067", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 18455228, is the following pharmacogenomic claim supported or contradicted: Allele A is associated with increased risk of Osteoporosis as compared to allele G. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs4355801 (PMID 18455228), what OR was reported?", "answer": "1.2", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000068", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25710119, is the following pharmacogenomic claim supported or contradicted: SLC6A4 L allele-rs25531T is not associated with response to milnacipran in people with Depressive Disorder, Major as compared to SLC6A4 L allele-rs25531C/L allele-rs25531C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T and milnacipran in Other:Major Depressive Disorder (PMID 25710119)?", "answer": 42, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000069", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26261165, is the following pharmacogenomic claim supported or contradicted: Allele T is not associated with response to escitalopram Depressive Disorder, Major as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs6311 and escitalopram in Other:Major Depressive Disorder (PMID 26261165)?", "answer": 55, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000070", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23691226, is the following pharmacogenomic claim supported or contradicted: Genotypes AA + AG is associated with increased dose of acenocoumarol as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs7200749 and acenocoumarol in Dosage (PMID 23691226)?", "answer": 3949, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000071", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 32606912, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 32606912, rs1800872 is associated with Dosage outcomes for sufentanil. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 32606912 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000072", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 27597944, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 27597944, HLA-DQB1*02:01 is associated with Toxicity outcomes for nevirapine. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 27597944 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000073", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 18322281, is the following pharmacogenomic claim supported or contradicted: Genotypes AA + AG is associated with decreased time to the first INR within the therapeutic range when treated with warfarin as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs2359612 and warfarin in Efficacy (PMID 18322281), what confidence interval was reported?", "answer": "1.06\u20131.92", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the HR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000074", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28525903, is the following pharmacogenomic claim supported or contradicted: Genotypes AG + GG are not associated with concentrations of methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype AA. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs2838958 and methotrexate in Disease:Acute lymphoblastic leukemia (PMID 28525903)?", "answer": 317, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000075", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 31493434, is the following pharmacogenomic claim supported, contradicted, or not reported: Allele T is not associated with response to heroin as compared to allele C. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 31493434 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000076", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 27005817, is the following pharmacogenomic claim supported or contradicted: Genotypes AG + GG are associated with increased platelet reactivity when treated with aspirin and clopidogrel in people with Coronary Artery Disease and Diabetes Mellitus, Type 2 as compared to genotype AA. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs13431554 and aspirin, clopidogrel in \"Disease:Coronary Artery Disease\", \"Disease:Diabetes Mellitus, Type 2\" (PMID 27005817)?", "answer": 674, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000077", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 19659438, is the following pharmacogenomic claim supported or contradicted: Allele C (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele T (assigned as normal metabolizer phenotype) . Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs28399499 and efavirenz in Disease:HIV infectious disease (PMID 19659438)?", "answer": 45, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000078", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 30723321, is the following pharmacogenomic claim supported or contradicted: Allele C is associated with increased response to migalastat in people with Fabry Disease. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs398123226 and migalastat in Other:Fabry Disease (PMID 30723321)?", "answer": 50, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000079", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 31721892, is the following pharmacogenomic claim supported or contradicted: Genotypes GT + TT are associated with decreased response to escitalopram in people with Depression as compared to genotype GG. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs1800532 and escitalopram in Other:Depression (PMID 31721892), what p-value was reported for this association?", "answer": "= 0.038", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000080", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28045923, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 28045923, rs11989215 is associated with Efficacy outcomes for bevacizumab. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 28045923 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000081", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 31461080, is the following pharmacogenomic claim supported or contradicted: CYP2C9 *1/*3 + *2/*2 + *2/*3 + *3/*3 are associated with increased risk of Drug Toxicity when treated with phenytoin as compared to CYP2C9 *1/*1. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of CYP2C9*1, CYP2C9*2, CYP2C9*3 and phenytoin in Toxicity (PMID 31461080), what HR was reported?", "answer": "2.4", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the HR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000082", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 20128861, is the following pharmacogenomic claim supported or contradicted: Allele C is not associated with dose of warfarin as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs11676382 and warfarin in Dosage (PMID 20128861)?", "answer": 145, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000083", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24590654, is the following pharmacogenomic claim supported or contradicted: Allele (CCGCGCCACTTGGCCTGCCTCCGTCCCG)2 is associated with increased likelihood of Diarrhea, Drug Toxicity or hand-foot syndrome when treated with capecitabine in people with Colorectal Neoplasms as compared to allele (CCGCGCCACTTGGCCTGCCTCCGTCCCG)3. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs45445694 and capecitabine in Disease:Colorectal Neoplasms (PMID 24590654), what OR was reported?", "answer": "1.44", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000084", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 18433502, is the following pharmacogenomic claim supported or contradicted: Allele T is not associated with response to ethanol as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs642489 and ethanol in Efficacy (PMID 18433502)?", "answer": 251, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000085", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28730340, is the following pharmacogenomic claim supported or contradicted: CYP2D6 poor metabolizer is not associated with likelihood of Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to CYP2D6 normal metabolizer. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of CYP2D6 poor metabolizer and tamoxifen in Disease:Breast Neoplasms (PMID 28730340), what confidence interval was reported?", "answer": "0.33\u20131.4", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the HR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000086", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 34158603, is the following pharmacogenomic claim supported or contradicted: Allele A is associated with increased risk of major adverse cardiac events (mace) when treated with aspirin and clopidogrel in people with Acute coronary syndrome as compared to allele G. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs3749187 and aspirin, clopidogrel in Other:Acute coronary syndrome (PMID 34158603), what p-value was reported for this association?", "answer": "= 3.37E-5", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000087", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 27114598, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with increased risk of Pancreatitis when treated with asparaginase in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to allele C. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs199695765 and asparaginase in Disease:Acute lymphoblastic leukemia (PMID 27114598)?", "answer": 3256, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000088", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26098993, is the following pharmacogenomic claim supported or contradicted: Genotype CC is associated with increased response to peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to genotypes CT + TT. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs12979860 and peginterferon alfa-2a, peginterferon alfa-2b, ribavirin in Disease:Hepatitis C virus infection (PMID 26098993), what p-value was reported for this association?", "answer": "= 0.008", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "counterfactual_evaluation", "question": "Would this association remain significant at alpha = 0.01? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000089", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 21801394, is the following pharmacogenomic claim supported or contradicted: Allele A is associated with increased risk of Epidermal Necrolysis, Toxic and Stevens-Johnson Syndrome when treated with allopurinol as compared to allele C. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs3094188 and allopurinol in Toxicity (PMID 21801394), what OR was reported?", "answer": "7.77", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000090", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 34464454, is the following pharmacogenomic claim supported or contradicted: Genotypes CT + TT are associated with increased response to cannabidiol in people with Epilepsy as compared to genotype CC. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs12539 and cannabidiol in Other:Epilepsy (PMID 34464454)?", "answer": 112, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000091", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 25148458, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 25148458, rs117996576 is associated with Metabolism/PK outcomes for anastrozole, exemestane. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 25148458 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000092", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 23213055, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 23213055, CYP2D6*1, CYP2D6*3, CYP2D6*4 is associated with Dosage, Efficacy, Toxicity, Metabolism/PK outcomes for tamoxifen. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 23213055 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
{"chain_id": "chain_000093", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 34871222, is the following pharmacogenomic claim supported or contradicted: Genotypes AA + AC are not associated with likelihood of Constipation, Delirium, Nausea, Pruritus, somnolence or Urinary Retention due to morphine or oxycodone in people with Lung Neoplasms as compared to genotype CC. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs324420 and morphine, oxycodone in Other:Lung Neoplasms (PMID 34871222), what OR was reported?", "answer": "0.7", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000094", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 19365400, is the following pharmacogenomic claim supported or contradicted: CYP2A6 *1/*35 + *9/*35 + *17/*35 are associated with decreased metabolism of nicotine as compared to CYP2A6 *1/*1. Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of CYP2A6*1, CYP2A6*9, CYP2A6*17, CYP2A6*35 and nicotine in Metabolism/PK (PMID 19365400)?", "answer": 284, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000095", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24060820, is the following pharmacogenomic claim supported or contradicted: CYP2D6 *3/*4 + *3/*5 + *3/*6 + *4/*11 + *4/*4 + *4/*5 + *4/*6 + *4/*7 + *5/*5 + *6/*6 + *6/*7 (assigned as poor metabolizer phenotype) are not associated with decreased event-free survival when treated with tamoxifen in women with Breast Neoplasms. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*11 and tamoxifen in Disease:Breast Neoplasms (PMID 24060820), what HR was reported?", "answer": "1.07", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the HR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000096", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 16476706, is the following pharmacogenomic claim supported or contradicted: Allele T is not associated with risk of Alcoholism or Cocaine-Related Disorders due to cocaine or ethanol as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "For the study of rs548646 and cocaine, ethanol in Toxicity (PMID 16476706), what p-value was reported for this association?", "answer": "= 0.576", "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "", "correct": false}]}
{"chain_id": "chain_000097", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 40184070, is the following pharmacogenomic claim supported or contradicted: CYP2C19 *1/*2 + *1/*3 + *2/*17 + *3/*17 + *2/*2 + *2/*3 + *3/*3 (assigned as intermediate metabolizer and poor metabolizer phenotype) is associated with increased likelihood of Stroke, Myocardial Infarction or Death when treated with clopidogrel in people with Stroke as compared to CYP2C19 *1/*1 + *1/*17 + *17/*17 (assigned as normal metabolizer phenotype) . Answer one of: supported, contradicted.", "answer": "supported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17 and clopidogrel in Other:Stroke (PMID 40184070)?", "answer": 2910, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000098", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmcid": null, "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 36614097, is the following pharmacogenomic claim supported or contradicted: Allele G is not associated with clinical benefit to aspirin, diclofenac, ibuprofen, indomethacin, ketorolac or naproxen in people with Migraine without Aura as compared to allele A. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases were included in the study of rs16944 and aspirin, diclofenac, ibuprofen, indomethacin, ketorolac, naproxen in Other:Migraine without Aura (PMID 36614097)?", "answer": 65, "response": "", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "", "correct": false}]}
{"chain_id": "chain_000099", "chain_family": "B_claim\u2192presence_absence", "pmcid": null, "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26030142, is the following pharmacogenomic claim supported, contradicted, or not reported: In PMID 26030142, rs35684750 is associated with Efficacy, Toxicity, Other outcomes for vancomycin. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 26030142 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "", "correct": false}]}
